Citation Impact
Citing Papers
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
2019
Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell–Independent Tumor Proliferation
2018
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation
2021
Head and neck squamous cell carcinoma
2020 Standout
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
2021
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
2015 StandoutNobel
Experimental models of inflammatory bowel disease
1995 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Activation‐induced cell death in T cells
2003
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Laparoscopic resection for rectal cancer: a prospective analysis of thirty-month follow-up outcomes in 312 patients
2006
mTOR co-targeting strategies for head and neck cancer therapy
2017
Minerals and vitamins in bone health: the potential value of dietary enhancement
2009
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Graft-versus-host disease
2007
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
2020
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
2020
Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment
2020
CELL DEATH AND IMMUNE PRIVILEGE
2002
Metabolism and action of amino acid analog anti-cancer agents
1990
Cytolytic pathways in haematopoietic stem-cell transplantation
2002
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
Macrophages in immunoregulation and therapeutics
2023 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria
2004 Standout
Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat
2005
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
2012 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
T cells require TRAIL for optimal graft-versus-tumor activity
2002
Pyroptosis: mechanisms and diseases
2021 Standout
Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Diseases
2008
Magnesium deficiency and osteoporosis: animal and human observations
2004
Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection
2003
Graft-versus-host disease
2009 Standout
T cell immune reconstitution following lymphodepletion
2007
Tumour-associated neutrophils in patients with cancer
2019
Increased Detectability of Plasma HIV‐1 RNA after Introduction of a New Assay and Altered Specimen‐Processing Procedures
2008
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
2009 Standout
Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease
2003
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Perturbations of both nonregulatory and regulatory FOXP3+ T cells in patients with malignant melanoma
2010 StandoutNobel
Bone Loss Induced by Dietary Magnesium Reduction to 10% of the Nutrient Requirement in Rats Is Associated with Increased Release of Substance P and Tumor Necrosis Factor-α
2004
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
2020
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
2018
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Towards improvements in molecular tools for diagnosis and management of HIV infections
1999 StandoutNobel
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Skin Ulcers Misdiagnosed as Pyoderma Gangrenosum
2002
Cancer and the chemokine network
2004 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Biofortification of crops with seven mineral elements often lacking in human diets – iron, zinc, copper, calcium, magnesium, selenium and iodine
2009 Standout
Ocular immune privilege: therapeutic opportunities from an experiment of nature
2003 Standout
The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities
2011 Standout
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease
2004
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation
2003
Magnesium in Man: Implications for Health and Disease
2014 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Therapeutic prospects of targeting myeloid‐derived suppressor cells and immune checkpoints in cancer
2018
Magnesium in Prevention and Therapy
2015 Standout
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Emergent autoimmunity in graft-versus-host disease
2005
Magnesium and Osteoporosis: Current State of Knowledge and Future Research Directions
2013
Efficiencies of Four Versions of the AMPLICOR HIV-1 MONITOR Test for Quantification of Different Subtypes of Human Immunodeficiency Virus Type 1
1999
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
2022 StandoutNobel
CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
2013 StandoutNobel
Some twists and turns in the path of improving surface activity
2002 StandoutNobel
Conversion of Alloantigen-Specific CD8+ T Cell Anergy to CD8+ T Cell Priming through In Vivo Ligation of Glucocorticoid-Induced TNF Receptor
2006 StandoutNobel
Adalimumab therapy for recalcitrant pyoderma gangrenosum.
2006
Ontogeny of the Mucosal Immune System and IgA Deficiency
1991
Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics
2019
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease
2003
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
Pulsed DC electric fields couple to natural NAD(P)H oscillations in HT-1080 fibrosarcoma cells
2001
Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10
2003
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Ellen Moore being referenced
Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade
2016
Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers
2016
Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ
2017
Aberrant Neutrophil Trafficking and Metabolic Oscillations in Severe Pyoderma Gangrenosum
1998
Almost all five year disease free survivors are cured following rectal cancer surgery, but longer term follow‐up detects some late local and systemic recurrences
2005
Influence of Pre-adolescent Diet on Quantitative Ultrasound Measurements of the Calcaneus in Young Adult Women
1999
Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies
2018
Comparison of HIV Type 1 RNA Plasma Viremia, p24 Antigenemia, and Unintegrated DNA as Viral Load Markers in Pediatric Patients
1996
Aberrant Integrin (CR4;αxβ2; CD11c/CD18) Oscillations on Neutrophils in a Mild Form of Pyoderma Gangrenosum
1998
GRAFT-VERSUS-HOST-DISEASE-ASSOCIATED THYMIC DAMAGE RESULTS IN THE APPEARANCE OF T CELL CLONES WITH ANTI-HOST REACTIVITY1
2000
Fas-DeficientlprMice Are More Susceptible to Graft-Versus-Host Disease
2000
Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA).
1980
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
2017
Antiretroviral Therapy Is Associated with a Decrease in Unintegrated HIV-1 DNA in Pediatric Patients
1994
REGIONAL DEFICIENCY OF SECRETORY IgA IN A PATIENT WITH COMBINED IMMUNODEFICIENCY OF THE ADA DEFICIENT TYPE
1979
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
2018
Discordance between Viral Loads Determined by Roche COBAS AMPLICOR Human Immunodeficiency Virus Type 1 Monitor (Version 1.5) Standard and Ultrasensitive Assays Caused by Freezing Patient Plasma in Centrifuged Becton-Dickinson Vacutainer Brand Plasma Preparation Tubes
2005
Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.
2000
mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer
2015